Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S100A9 | P06702 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.37 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.34 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22978658 | 1.00 | S100A9 (0.41) | S100A9ALDH1A1LMNACHRNB2CHRNA4 | |
| SCHEMBL10148219 | 0.84 | ALDH1A1 (0.41) | S100A9ALDH1A1LMNACHRNB2CHRNA4 | |
| SCHEMBL1549298 | 0.80 | ALDH1A1 (0.39) | ALDH1A1MAPT | |
| SCHEMBL2420286 | 0.80 | ALDH1A1 (0.39) | ALDH1A1MAPT | |
| SCHEMBL2420288 | 0.80 | ALDH1A1 (0.39) | ALDH1A1MAPT | |
| SCHEMBL30388361 | 0.80 | ALDH1A1 (0.39) | ALDH1A1MAPT | |
| SCHEMBL13859196 | 0.78 | CHRNB2 (0.33) | ALDH1A1CHRNB2CHRNA4 | |
| SCHEMBL23534388 | 0.78 | ALDH1A1 (0.37) | S100A9ALDH1A1LMNACHRNB2CHRNA4 | |
| SCHEMBL24122821 | 0.77 | CYP11B2 (0.37) | CYP11B1CYP11B2 | |
| SCHEMBL22990521 | 0.77 | P2RX7 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4010334-A1 | HETEROCYCLIC WDR5 INHIBITORS AS ANTI-CANCER COMPOUNDS | Novartis AG (CH) | 2022-06-15 | — | — | EP | disclosed |